ConductScience.org, home

Paper40319178

Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy.

Sun L and 16 others. Cell Death Differ, 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy. Papers, record 40319178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40319178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deacetylation of ANXA2 by SIRT2 desensitizes hepatocellular carcinoma cells to donafenib via promoting protective autophagy.
PubMed
Journal
Cell Death Differ
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
2.68, provisional
iCite
Revised in PubMed
2026-09-13
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun LLiangbohttps://orcid.org/0000-0001-7405-451X
2He MMeng
3Liu DDong
4Shan MMeihua
5Chen LLingxi
6Yang MMingzhen
7Dai XXufang
8Yao JJie
9Li TTao
10Zhang YYan
11Zhang YYang
12Xiang LLi
13Chen AAn
14Hao YYingxuehttps://orcid.org/0009-0001-2649-3814
15He FFengtianhttps://orcid.org/0000-0001-8526-394X
16Xiong HHaojunhttps://orcid.org/0000-0002-7425-3962
17Lian JJiqinhttps://orcid.org/0000-0002-8708-6171

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sirtuin 2Major topic
Carcinoma, HepatocellularMajor topic
AutophagyMajor topic
Liver NeoplasmsMajor topic
Annexin A2Major topic
PyridinesMajor topic
Humans
Acetylation
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82273114National Natural Science Foundation of China (National Science Foundation of China)PubMed
82073300National Natural Science Foundation of China (National Science Foundation of China)PubMed
32300626National Natural Science Foundation of China (National Science Foundation of China)PubMed
82273112National Natural Science Foundation of China (National Science Foundation of China)PubMed
CSTB2022NSCQ-LZX0018Natural Science Foundation of Chongqing (Natural Science Foundation of Chongqing Municipality)PubMed
CSTB2023NSCQ-MSX0651Natural Science Foundation of Chongqing (Natural Science Foundation of Chongqing Municipality)PubMed
2022XQN05Third Military Medical University (TMMU)PubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128166203LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.Oncogene2017https://conductscience.org/library/papers/28166203PubMed
218332217The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.J Cell Biol2008https://conductscience.org/library/papers/18332217PubMed
325484070Posttranslational modification of autophagy-related proteins in macroautophagy.Autophagy2015https://conductscience.org/library/papers/25484070PubMed
4284652575-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.Cancer Lett2017https://conductscience.org/library/papers/28465257PubMed
536369487Evolving therapeutic landscape of advanced hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2023https://conductscience.org/library/papers/36369487PubMed
639097092ADAM8 deficiency in macrophages promotes cardiac repair after myocardial infarction via ANXA2-mTOR-autophagy pathway.J Adv Res2025https://conductscience.org/library/papers/39097092PubMed
72960386Annexins--new family of Ca2+-regulated-phospholipid binding protein.Biosci Rep1987https://conductscience.org/library/papers/2960386PubMed
835042977Modulation of cellular processes by histone and non-histone protein acetylation.Nat Rev Mol Cell Biol2022https://conductscience.org/library/papers/35042977PubMed
935250553Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells.Front Pharmacol2021https://conductscience.org/library/papers/35250553PubMed
1029433850Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.Lancet2018https://conductscience.org/library/papers/29433850PubMed
1130081903ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/30081903PubMed
1236931971Recent advances in targeting autophagy in cancer.Trends Pharmacol Sci2023https://conductscience.org/library/papers/36931971PubMed
1333872660Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.Life Sci2021https://conductscience.org/library/papers/33872660PubMed
1433602787HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.Cancer Res2021https://conductscience.org/library/papers/33602787PubMed
1527634758NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.Cancer Res2016https://conductscience.org/library/papers/27634758PubMed
1634591285Donafenib: First Approval.Drugs2021https://conductscience.org/library/papers/34591285PubMed
1735474212Annexin A2: The diversity of pathological effects in tumorigenesis and immune response.Int J Cancer2022https://conductscience.org/library/papers/35474212PubMed
1822705595Clinical and prognostic role of annexin A2 in multiple myeloma.Blood2012https://conductscience.org/library/papers/22705595PubMed
1934624198Current epidemiology in hepatocellular carcinoma.Expert Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/34624198PubMed
2038290972ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.Autophagy2024https://conductscience.org/library/papers/38290972PubMed

See all 51 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42765004Nanomaterial-driven spatiotemporal autophagy modulation: The dual-edged sword in precision cancer therapy.Acta Pharm Sin B2026https://conductscience.org/library/papers/42765004PubMed
42512290Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy.Cancers (Basel)2026https://conductscience.org/library/papers/42512290PubMed
42404106Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives.J Hepatocell Carcinoma2026https://conductscience.org/library/papers/42404106PubMed
42310746SerpinB7 promotes c-Myc-mediated glycolysis by interacting with ANXA2 to facilitate the progression of non-small cell lung cancer.Mol Cancer2026https://conductscience.org/library/papers/42310746PubMed
42213854CEMs-SELEX: DNAzyme-powered de novo biomarker discovery and noninvasive cancer diagnosis.Sci Adv2026https://conductscience.org/library/papers/42213854PubMed
42089471The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential.FEBS J2026https://conductscience.org/library/papers/42089471PubMed
41425553Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons.Front Immunol2025https://conductscience.org/library/papers/41425553PubMed
41185558VSIG2 hinders gastric cancer progression by suppressing ANXA2-mediated NF-κB pathway activation.Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/41185558PubMed
41108510Post-translational modifications in hepatocellular carcinoma: mechanisms and therapeutic potential.Med Oncol2025https://conductscience.org/library/papers/41108510PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA2302PubTator's text mininghttps://conductscience.org/library/genes/302NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
SIRT222933PubTator's text mininghttps://conductscience.org/library/genes/22933NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40319178

GET https://conductscience.org/api/papers/v1/40319178/references?page=2